Skip to content

An Ayurvedic approach to Diabesity

A clinical study on Prameha w.s.r to Diabesity and its management with Vidangadi churnam and Udvartana - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067387
Enrollment
60
Registered
2024-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Dr Lipsa Mohapatra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: BMI : 25-30kg/m² Stage 1 and stage 2 HTN under medication FBS : 126mg/dl - 160mg/dl PPBS : 200mg/dl - 250mg/dl HbA1C : 6.5% - 7% Total serum Cholesterol: 200mg/dl - 240mg/dl Triglycerides: 150mg/dl - 200mg/dl LDL Cholesterol: 100mg/dl - 160mg/dl HDL Cholesterol: 40mg/dl - 60mg/dl

Exclusion criteria

Exclusion criteria: Type 1 Diabetes, Hypertensive Crisis Diabetic Complications like Neuropathy, Nephropathy, Retinopathy Pregnant & Lactating women, Gestational DM Congenital anomalies, Venereal diseases Acute and Chronic contagious diseases Complicated metabolic syndromes,CVD, CHD, CKD

Design outcomes

Primary

MeasureTime frame
To maintain normoglycemiic index aiding with hypolipidemic effectTimepoint: 30days

Secondary

MeasureTime frame
Improve quality of life by complementing immunomodulatory actions and antioxidant propertiesTimepoint: 30days

Countries

India

Contacts

Public ContactDr Sonalika Jena

Gopabandhu Ayurveda Mahavidyalaya

drsonalikajena@gmail.com9437281398

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026